Home Cart 0 Sign in  
X

[ CAS No. 228410-90-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 228410-90-0
Chemical Structure| 228410-90-0
Chemical Structure| 228410-90-0
Structure of 228410-90-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 228410-90-0 ]

Related Doc. of [ 228410-90-0 ]

Alternatived Products of [ 228410-90-0 ]

Product Details of [ 228410-90-0 ]

CAS No. :228410-90-0 MDL No. :MFCD06659520
Formula : C6H5BrN2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :QXPNHVCGSASGIX-UHFFFAOYSA-N
M.W : 233.02 Pubchem ID :21706517
Synonyms :

Calculated chemistry of [ 228410-90-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 48.55
TPSA : 78.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.92
Log Po/w (XLOGP3) : 0.57
Log Po/w (WLOGP) : 1.35
Log Po/w (MLOGP) : 0.28
Log Po/w (SILICOS-IT) : 0.52
Consensus Log Po/w : 0.73

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.95
Solubility : 2.63 mg/ml ; 0.0113 mol/l
Class : Very soluble
Log S (Ali) : -1.79
Solubility : 3.74 mg/ml ; 0.016 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.56
Solubility : 0.643 mg/ml ; 0.00276 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.18

Safety of [ 228410-90-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 228410-90-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 228410-90-0 ]
  • Downstream synthetic route of [ 228410-90-0 ]

[ 228410-90-0 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 2
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 3
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 4
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 5
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 6
  • [ 100367-40-6 ]
  • [ 228410-90-0 ]
YieldReaction ConditionsOperation in experiment
85% With sulfuric acid; sodium nitrite In water at 0 - 100℃; for 6 h; To a solution of 5-bromo-4-methyl-3-nitropyridin-2-amine (28 g, 121 mmol) in water (900 ml) was added H2S04 (28 ml) followed by NaN02 (20.91 g, 303 mmol) in water (100 ml) drop wise at 0°C. The reaction mixture was slowly warmed to room temperature for 2h, the reaction mixture was heated at 100°C for 4h. The solid formed in reaction mixture was filtered and dried to afford title compound as a pale yellow solid (24.0 g, 85 percent); 1H NMR (400 MHz, DMSO-de) δ 12.97 (s, 1H), 8.01 (s, 1H), 2.21 (s, 3H); LC/MS: 233 (M+l)+.
Reference: [1] Patent: WO2014/125408, 2014, A2, . Location in patent: Page/Page column 38
  • 7
  • [ 21901-18-8 ]
  • [ 228410-90-0 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 5, p. 460 - 465
  • 8
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 9
  • [ 6635-86-5 ]
  • [ 228410-90-0 ]
Reference: [1] Patent: WO2014/125408, 2014, A2,
  • 10
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 11
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 12
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 13
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 14
  • [ 228410-90-0 ]
  • [ 74-88-4 ]
  • [ 1446237-40-6 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5 h;
Stage #2: at 20℃; for 3 h;
Step 1.
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
A solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (15.00 g, 64.37 mmol) [Combi-Blocks, AN-1086] in N,N-dimethylformamide (250 mL) was treated with sodium hydride (3.09 g, 77.3 mmol) (60percent dispersion on mineral oil) slowly and portionwise, and stirred at RT for 30 min.
The reaction mixture was treated with methyl iodide (4.81 mL, 77.2 mmol) dropwise and stirred at RT for 3 h. LCMS indicated a clean peak for methylated product.
The reaction mixture was poured over water/ice (˜400 mL) and allowed to stir while the ice melted.
The aqueous mixture was extracted with EA.
The organic layer was washed with water (3*) and brine, dried with magnesium sulfate, filtered, and concentrated to give the desired product (14.9 g, 93percent) that was used without further purification. LCMS calculated for C7H8BrN2O3 (M+H)+: m/z=247.0, 249.0. found: 247.0, 248.9.
93%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5 h;
Stage #2: at 20℃; for 3 h;
Step 1.
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
A solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (15.00 g, 64.37 mmol) [Combi-Blocks, AN-1086] in N,N-dimethylformamide (250 mL) was treated with sodium hydride (3.09 g, 77.3 mmol) (60percent dispersion on mineral oil) slowly and portionwise, and stirred at RT for 30 min.
The reaction mixture was treated with methyl iodide (4.81 mL, 77.2 mmol) dropwise and stirred at RT for 3 h. LCMS indicated a clean peak for methylated product.
The reaction mixture was poured over water/ice (˜400 mL) and allowed to stir while the ice melted.
The aqueous mixture was extracted with ethyl acetate.
The organic layer was washed with water (3*) and brine, dried with magnesium sulfate, filtered, and concentrated to give the desired product (14.9 g, 93percent) that was used without further purification. LCMS calculated for C7H8BrN2O3 (M+H)+: m/z=247.0, 249.0. found: 247.0, 248.9.
92% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; To a solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (24 g, 103 rnmol) in DMF (200 ml) was added K2CO3 (21.39 g, 155 mmol) and CH3I (21.86 g, 155 mmol). The reaction mixture was stirred at room temperature for 2h. The reaction mixture was poured into ice cold water, the solid formed was filtered and dried under vacuum to afford title compound as off white solid (23.5 g, 92 percent). FontWeight="Bold" FontSize="10" H NMR (400 MHz, DMSO-d6) δ 8.40 (s, 1H), 3.51 (s, 3H), 2.21 (s, 3H).
Reference: [1] Patent: US2015/148375, 2015, A1, . Location in patent: Paragraph 0309; 0310
[2] Patent: US2015/148342, 2015, A1, . Location in patent: Paragraph 0336; 0337
[3] Patent: WO2014/125408, 2014, A2, . Location in patent: Page/Page column 38; 39
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 228410-90-0 ]

Bromides

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.96

Chemical Structure| 15862-34-7

[ 15862-34-7 ]

5-Bromo-2-hydroxy-3-nitropyridine

Similarity: 0.88

Chemical Structure| 525593-33-3

[ 525593-33-3 ]

3-Bromo-5-nitroindole

Similarity: 0.71

Chemical Structure| 98786-86-8

[ 98786-86-8 ]

3-Amino-5-bromopyridin-2(1H)-one

Similarity: 0.71

Chemical Structure| 881-50-5

[ 881-50-5 ]

N-(4-Bromo-2-nitrophenyl)acetamide

Similarity: 0.70

Amides

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.96

Chemical Structure| 15862-34-7

[ 15862-34-7 ]

5-Bromo-2-hydroxy-3-nitropyridine

Similarity: 0.88

Chemical Structure| 21901-18-8

[ 21901-18-8 ]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.84

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.74

Chemical Structure| 98786-86-8

[ 98786-86-8 ]

3-Amino-5-bromopyridin-2(1H)-one

Similarity: 0.71

Nitroes

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.96

Chemical Structure| 15862-34-7

[ 15862-34-7 ]

5-Bromo-2-hydroxy-3-nitropyridine

Similarity: 0.88

Chemical Structure| 21901-18-8

[ 21901-18-8 ]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.84

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.74

Chemical Structure| 525593-33-3

[ 525593-33-3 ]

3-Bromo-5-nitroindole

Similarity: 0.71

Related Parent Nucleus of
[ 228410-90-0 ]

Pyridines

Chemical Structure| 1446237-40-6

[ 1446237-40-6 ]

5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one

Similarity: 0.96

Chemical Structure| 15862-34-7

[ 15862-34-7 ]

5-Bromo-2-hydroxy-3-nitropyridine

Similarity: 0.88

Chemical Structure| 21901-18-8

[ 21901-18-8 ]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.84

Chemical Structure| 6332-56-5

[ 6332-56-5 ]

3-Nitropyridin-2(1H)-one

Similarity: 0.74

Chemical Structure| 98786-86-8

[ 98786-86-8 ]

3-Amino-5-bromopyridin-2(1H)-one

Similarity: 0.71